ATE426662T1 - Feedback resistante mevalonate kinase - Google Patents

Feedback resistante mevalonate kinase

Info

Publication number
ATE426662T1
ATE426662T1 AT04736497T AT04736497T ATE426662T1 AT E426662 T1 ATE426662 T1 AT E426662T1 AT 04736497 T AT04736497 T AT 04736497T AT 04736497 T AT04736497 T AT 04736497T AT E426662 T1 ATE426662 T1 AT E426662T1
Authority
AT
Austria
Prior art keywords
mevalonate kinase
feedback resistant
resistant mevalonate
vectors
producing
Prior art date
Application number
AT04736497T
Other languages
English (en)
Inventor
Renyunan Bai
Mbelin Markus H
Martin Lehmann
Rual Lopez-Ulibarri
Markus Wyss
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE426662T1 publication Critical patent/ATE426662T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04736497T 2003-06-12 2004-06-10 Feedback resistante mevalonate kinase ATE426662T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03012294 2003-06-12

Publications (1)

Publication Number Publication Date
ATE426662T1 true ATE426662T1 (de) 2009-04-15

Family

ID=33547583

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04736497T ATE426662T1 (de) 2003-06-12 2004-06-10 Feedback resistante mevalonate kinase

Country Status (9)

Country Link
US (1) US7422884B2 (de)
EP (1) EP1631664B1 (de)
JP (1) JP4643569B2 (de)
KR (1) KR101190897B1 (de)
CN (1) CN1806042B (de)
AT (1) ATE426662T1 (de)
DE (1) DE602004020218D1 (de)
ES (1) ES2323175T3 (de)
WO (1) WO2004111214A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1824969B1 (de) * 2004-12-14 2011-03-02 DSM IP Assets B.V. Verbesserte mevalonatkinase
EP2371967B1 (de) 2005-03-18 2015-06-03 DSM IP Assets B.V. Produktion von Carotenoiden in Ölhaltigen Hefen und Pilzen
DK3020799T3 (da) 2006-09-26 2020-09-21 Amyris Biotechnologies Inc Fremstilling af isoprenoider og isoprenoid-prækursorer
US8691555B2 (en) 2006-09-28 2014-04-08 Dsm Ip Assests B.V. Production of carotenoids in oleaginous yeast and fungi
JP2009000046A (ja) * 2007-06-21 2009-01-08 Hitachi Zosen Corp トチュウのメバロン酸経路の酵素をコードする遺伝子
DK2235190T3 (en) 2007-12-13 2018-07-23 Danisco Us Inc COMPOSITIONS AND PROCEDURES FOR PRODUCING ISOPRENE
JP2011518564A (ja) 2008-04-23 2011-06-30 ダニスコ・ユーエス・インク 改良された微生物によるイソプレン産出用のイソプレンシンターゼ変異体
EP2157174A1 (de) 2008-08-12 2010-02-24 DSM IP Assets B.V. Erhöhte Produktion von Pantothenate (Vitamin B5)
MY169163A (en) 2008-09-15 2019-02-19 Danisco Us Inc Increased isoprene production using the archaeal lower mevalonate pathway
US8518686B2 (en) 2009-04-23 2013-08-27 Danisco Us Inc. Three-dimensional structure of isoprene synthase and its use thereof for generating variants
EP2336310A1 (de) 2009-12-16 2011-06-22 Isobionics B.V. Valencensynthase
EP2575432B1 (de) 2010-06-02 2019-08-14 Evolva, Inc. Rekombinante herstellung von steviol-glycosiden
WO2012014228A1 (en) 2010-07-28 2012-02-02 Abhishek Narain Singh A method to by-pass allosteric domain activity of an enzyme so as to alter its feedback or feed-forward inhibition or activation
WO2012019169A1 (en) * 2010-08-06 2012-02-09 Danisco Us Inc. Production of isoprene under neutral ph conditions
CN103443271A (zh) 2010-10-27 2013-12-11 丹尼斯科美国公司 用于增加异戊二烯产量的异戊二烯合酶变体
EP2537926A1 (de) 2011-06-21 2012-12-26 Isobionics B.V. Valencensynthase
EP2723878B1 (de) 2011-06-21 2020-05-20 DSM IP Assets B.V. Herstellung von vitamin b5
WO2012175574A1 (en) 2011-06-21 2012-12-27 Dsm Ip Assets B.V. Increased pantothenate (vitamin b5) production
EP2739742A1 (de) 2011-08-05 2014-06-11 Danisco US Inc. Herstellung von isoprenoiden unter neutralen ph-bedingungen
AU2012294452C1 (en) 2011-08-08 2017-11-30 Danstar Ferment Ag Recombinant production of steviol glycosides
CN103205432B (zh) * 2012-01-11 2015-06-10 安徽医科大学第一附属医院 弥散型浅表性光线性汗孔角化症(dsap)相关基因
US9163263B2 (en) 2012-05-02 2015-10-20 The Goodyear Tire & Rubber Company Identification of isoprene synthase variants with improved properties for the production of isoprene
WO2014122227A2 (en) 2013-02-06 2014-08-14 Evolva Sa Methods for improved production of rebaudioside d and rebaudioside m
BR112015019160A2 (pt) 2013-02-11 2017-08-22 Dalgaard Mikkelsen Michael Produção de glicosídeos de esteviol em hospedeiros recombinantes
RU2014112066A (ru) 2014-03-28 2015-10-10 Адзиномото Ко., Инк. Способ получения мономерного изопрена
CN114410493A (zh) 2014-08-11 2022-04-29 埃沃尔瓦公司 在重组宿主中生产甜菊醇糖苷
KR20170052647A (ko) 2014-09-09 2017-05-12 에볼바 에스아 재조합 숙주에서 스테비올 글리코시드의 생성
AU2016211124B2 (en) 2015-01-30 2022-04-14 Danstar Ferment Ag Production of steviol glycosides in recombinant hosts
EP3271457B1 (de) 2015-03-16 2021-01-20 DSM IP Assets B.V. Udp-glycosyltransferasen
EP3332018B1 (de) 2015-08-07 2022-07-27 Evolva SA Erzeugung von steviolglycosiden in rekombinanten wirten
KR20180132696A (ko) 2016-04-13 2018-12-12 에볼바 에스아 재조합 숙주에서의 스테비올 글리코사이드의 생산
US10815514B2 (en) 2016-05-16 2020-10-27 Evolva Sa Production of steviol glycosides in recombinant hosts
WO2018083338A1 (en) 2016-11-07 2018-05-11 Evolva Sa Production of steviol glycosides in recombinant hosts
NL2018457B1 (en) 2017-03-02 2018-09-21 Isobionics B V Santalene Synthase
NL2019473B1 (en) 2017-09-01 2019-03-11 Isobionics B V Terpene Synthase producing patchoulol and elemol, and preferably also pogostol
KR102092075B1 (ko) * 2017-10-27 2020-03-23 경상대학교산학협력단 MmMVK-메발론산 복합체의 3차원 결정 구조 및 기질저해 저항성 돌연변이 메발론산 인산화효소
KR20200095534A (ko) 2017-12-07 2020-08-10 지머젠 인코포레이티드 발효에 의한 (6e)-8-히드록시제라니올의 제조를 위해 조작된 생합성 경로
WO2019126778A1 (en) 2017-12-21 2019-06-27 Zymergen Inc. Nepetalactol oxidoreductases, nepetalactol synthases, and microbes capable of producing nepetalactone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI250210B (en) * 1998-05-06 2006-03-01 Dsm Ip Assets Bv An isolated DNA sequence coding for an enzyme involved in the mevalonate pathway or the pathway from isopentenyl pyrophosphate to farnesyl pyrophosphate
EP1392824B1 (de) 2001-06-06 2008-08-20 DSM IP Assets B.V. Verbesserte isoprenoid herstellung

Also Published As

Publication number Publication date
DE602004020218D1 (de) 2009-05-07
WO2004111214A1 (en) 2004-12-23
CN1806042B (zh) 2012-07-04
JP4643569B2 (ja) 2011-03-02
ES2323175T3 (es) 2009-07-08
EP1631664B1 (de) 2009-03-25
JP2007523612A (ja) 2007-08-23
US7422884B2 (en) 2008-09-09
KR101190897B1 (ko) 2012-10-12
KR20060022692A (ko) 2006-03-10
EP1631664A1 (de) 2006-03-08
CN1806042A (zh) 2006-07-19
US20070141685A1 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
DE602004020218D1 (de) Feedback resistante mevalonate kinase
ATE500321T1 (de) Verbesserte mevalonatkinase
WO2005023824A3 (en) Methods for inhibiting tumor cell proliferation
AP2005003383A0 (en) Aminoheteroaryl compounds as protein kinase inhibitors.
MX391408B (es) Inhibidores de biaril meta-pirimidina de cinasas.
WO2003081210A3 (en) Identification of kinase inhibitors
AU2003255779A1 (en) 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors
NO20066050L (no) Substituerte indazoler, sammensetninger inneholdende disse samt fremstilling og anvendelse derav
MY141867A (en) Substituted pyrimidines useful as protein kinase inhibitors
WO2002044331A3 (en) Dap-kinase and hoxa9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer
BR0315233A (pt) Derivados de azaindol como inibidores de p38 cinase
TW200731094A (en) Extensible meta-data
DE60323749D1 (de) Substituierte pyrroline als kinase inhibitoren
PH12012502411A1 (en) Method of modulating stress-activated protein kinase system
ATE361922T1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
CY1108092T1 (el) Ενωσεις και μεθοδοι για την αναστολη της μιτωτικης προοδου με την αναστολη της κινασης aurora
MXPA06003297A (es) Metodo de servicio de certificacion segura.
WO2001064681A3 (en) 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
MY146989A (en) Kinase inhibitors
EP1560120A4 (de) Zugriffsverfahren
NO20040193L (no) Stabilisert kraftforsyningssystem og fremgangsmate til drift av samme, samt dataprogram
WO2009054939A3 (en) Cancer classification and methods of use
MXPA05009151A (es) Inhibidores de cinasa heterociclica.
NO20025686D0 (no) Storsekk, samt fremgangsmåte til fremstilling av denne
WO2003084475A3 (en) INHIBITORS OF THE S100-p53 PROTEIN-PROTEIN INTERACTION AND METHOD OF INHIBITING CANCER EMPLOYING THE SAME

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties